Vanda Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved BYSANTItm (milsaperidone) tablets, a first line therapy for the acute treatment of manic or ...

Inspired by the simple mechanism of a seesaw—when one side goes up, the other side goes down—researchers asked an intriguing question: Could a single molecule switch between two different roles like a ...

Ozempic has been making headlines for its remarkable success in treating obesity and diabetes. Yet it is just one in a rapidly growing class of drugs called peptide therapeutics that sits between ...

A study on worms led by researchers from Vanderbilt University School of Medicine in the US has uncovered a previously unknown adaptation to aging that actively remodels one of the largest and most ...

BACKGROUND: The entrance of naive T cells into lymph nodes (LNs) is a crucial step for induction of heart transplant acceptance under costimulatory blockade. Specialized blood vessels within the LN ...

The Caltech professor on using AI to harness the power of enzymes — and what US funding cuts could mean for research ...

Scientists in Japan have uncovered a bacterial duo in the gut that might explain why millions of people struggle with chronic constipation, especially when traditional treatments fail. Their work ...

Free download: new edition explains common canine health problems, helps recognize them, shares what to do about them ...

If you're looking for the quickest way to sober up, you'll want to try these top tips that are proven to help you shake off a ...

Researchers at the Max Delbrück Center show that two related enzymes, MNK1 and MNK2, act on the brain to regulate different behaviors.